Submitted by Anonymous (not verified) on 5 October 2023 - 13:24
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Lymphoma, Large B-Cell, Diffuse, Date of authorisation: 22/09/2023, Status: Authorised
Source:
